Home/Eikon Therapeutics/Dr. Luke Lairson
DL

Dr. Luke Lairson

Vice President, Discovery Chemistry

Eikon Therapeutics

Therapeutic Areas

Eikon Therapeutics Pipeline

DrugIndicationPhase
Undisclosed Small Molecule ProgramOncology (Target Undisclosed)Preclinical